Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 152	$ 1,680
Trade accounts and other receivables	2,729	1,986
Allowance for doubtful accounts	(6)	(8)
Trade accounts and other receivables – net	2,723	1,978
Inventories	320	379
Derivative assets	323	301
Other current assets and deferred charges	279	211
Total current assets	3,797	4,549
Investments	5,065	5,127
Property, plant, and equipment – net	30,889	29,258
Intangible assets – net of accumulated amortization	7,363	7,402
Regulatory assets, deferred charges, and other	1,319	1,276
Total assets	48,433	47,612
Current liabilities:
Accounts payable	2,327	1,746
Derivative Liability, Current	316	166
Accrued and other current liabilities	1,270	1,035
Commercial Paper	350	0
Long-term debt due within one year	627	2,025
Total current liabilities	4,890	4,972
Long-term debt	21,927	21,650
Deferred income tax liabilities	2,887	2,453
Regulatory liabilities, deferred income, and other	4,684	4,436
Contingent liabilities and commitments (Note 17)
Stockholders’ equity:
Preferred stock ($1 par value; 30 million shares authorized at December 31, 2022 and December 31, 2021; 35,000 shares issued at December 31, 2022 and December 31, 2021)	35	35
Common stock ($1 par value; 1,470 million shares authorized at December 31, 2022 and December 31, 2021; 1,253 million shares issued at December 31, 2022 and 1,250 million shares issued at December 31, 2021)	1,253	1,250
Capital in excess of par value	24,542	24,449
Retained deficit	(13,271)	(13,237)
Accumulated other comprehensive income (loss)	(24)	(33)
Treasury stock, at cost (35 million shares of common stock)	(1,050)	(1,041)
Total stockholders’ equity	11,485	11,423
Noncontrolling interests in consolidated subsidiaries	2,560	2,678
Total equity	14,045	14,101
Total liabilities and equity	$ 48,433	$ 47,612